Financial News
Dynavax Technologies (NQ: DVAX )
10.45
+0.20
(+1.95%)
Streaming Delayed Price
Updated: 10:55 AM EDT, Jul 22, 2024
Add to My Watchlist
All News about Dynavax Technologies
![](https://investorplace.com/wp-content/uploads/2022/05/small-cap-1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/dvax_logo_light__6a5a285e753b67e312909582a4db2228.png?width=1200&height=800&fit=crop)
Dynavax Adjuvant Based COVID-19 Vaccine Lowers The Risk Of Transmission
November 30, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/f3d0fcc1-60b4-46be-bacb-411620e9c881/small/300-dpi-logo-jpg.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_5791.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/20/covid_vaccine-photo_by_hakan_german_from_pixabay.jpg?width=1200&height=800&fit=crop)
China-Based COVID-19 Shot Neutralizes Omicron Subvariants
September 20, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/small-cap-1600-1024x576.png)
![](https://ml.globenewswire.com/media/f3d0fcc1-60b4-46be-bacb-411620e9c881/small/300-dpi-logo-jpg.jpg)
Clover Provides Update on 2022 Corporate Milestones
October 09, 2022
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_4412.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2022
September 27, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/short_image_331.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/20/image22.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/12/bz-pharma_5.jpg?width=1200&height=800&fit=crop)
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/19/image24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/25/bz-pharma_2.jpg?width=1200&height=800&fit=crop)
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 25, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/25/aapharma_10.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_257.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/07/watch2.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13322.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://www.investors.com/wp-content/uploads/2018/12/stock-medical-trials-01-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
![](https://www.investors.com/wp-content/uploads/2019/09/stock-drug-research-01-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.